Medicaid coverage for tobacco-dependence treatments

Health Affairs
Helen A HalpinSara B McMenamin

Abstract

This paper presents an update on the availability of tobacco-dependence treatments in Medicaid benefit packages from 1998 to 2003 and discusses variation in states' approaches for addressing tobacco cessation. In 2003 thirty-seven states had coverage for at least one evidence-based treatment. Since 1998, thirteen Medicaid programs have added coverage for at least one, while five programs have expanded coverage of these treatments. Overall, the coverage increases indicate a growing awareness of the treatments' importance for the health of Medicaid recipients, although further expansions are still needed.

References

Jun 1, 1992·Patient Education and Counseling
Feb 24, 2001·Health Affairs·H H SchaufflerC T Orleans
Jan 31, 2004·American Journal of Preventive Medicine·Sara B McMenaminC Tracy Orleans

❮ Previous
Next ❯

Citations

Nov 16, 2010·Administration and Policy in Mental Health·Jill M WilliamsJonathan Foulds
May 15, 2007·Medical Care·Nicole M BellowsHelen Ann Halpin
Mar 22, 2014·American Journal of Preventive Medicine·Jessica GreeneSara B McMenamin
May 23, 2012·American Journal of Preventive Medicine·Chenghui Li, Carolyn M Dresler
Jan 6, 2009·The Milbank Quarterly·Sarah E GollustKenneth E Warner
Feb 5, 2015·JMIR MHealth and UHealth·Lorien C AbromsJessica A Bushar
May 10, 2019·The Milbank Quarterly·Hugh Alderwick, Laura M Gottlieb
May 15, 2009·International Journal of Environmental Research and Public Health·Jennifer W KahendeAnn Malarcher
Nov 27, 2020·Economics and Human Biology·Lianlian Lei, Feng Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.